Press

Founded by a Victoria-based communications professional and cancer survivor who was pushed into menopause chemically and then surgically — and found almost no map for any of it.

BC began offering free public coverage of hormone replacement therapy in March 2026. Western Canada's first Complex Menopause Clinic opened at BC Women's Hospital in 2025. Globally, an estimated 1.2 billion women will be in or past menopause by 2030. The average time from first perimenopause symptoms to diagnosis is still 4.6 years. Nila is built to close that gap.

The economic picture in Canada is now quantified. Unmanaged menopause symptoms cost the Canadian economy an estimated $3.5 billion a year — $3.3 billion in lost income borne by women themselves (reduced hours, reduced pay, or leaving the workforce) and $237 million in lost employer productivity, roughly 540,000 lost workdays. Of the women surveyed, 95% report symptoms (an average of seven of 30+), 46% felt unprepared, and 87% say their employer offers no menopause support or they don't know if it does.

Source: Menopause Foundation of Canada, Menopause and Work in Canada (Deloitte / Leger, October 2023).

Research is evidence-based and sources are visible on every clinical claim. The community is moderated for substance. Symptom tracking stays private — no data sold or shared. The platform is built wide on purpose: whether menopause arrived on its own timeline, after surgery, after cancer treatment, or alongside ADHD, autism, or a body that doesn't fit one script, the doorway is the same. Paid placements are clearly marked and never appear in editorial content, or on counselling, identity, or crisis pages.

What Nila is not: a single-feature AI coach or a symptom-tracker with a chat bubble bolted on. Nila is one surface of the product — the front door to a moderated community, an evidence-based research library, symptom and treatment guides, and a private check-in. The chat is the welcome, not the whole house.

Lane-by-lane comparison: hellonila.com/why-nila

App screenshots are now live. For anything else, or higher-resolution variants, email info@hellonila.com.

Erin Beattie is a communications professional and cancer survivor based in Victoria, BC. Cancer treatment pushed her into menopause chemically, and surgery finished the job — a fast, disorienting version of a transition most resources still describe as gradual. Building community is the thread through her work: Nila is the room she needed and couldn't find, opened up for everyone else navigating the same ground. She is available for interview.

Photo · Bio · hellonila.com/about

Nila enters a category that is finally being priced honestly. Roughly 6% of private healthcare investment goes to women's health, against a FemTech market projected to grow from US$39B in 2024 to US$97B by 2030. The untapped menopause-medication market alone is estimated at US$120–230B/year. 450 million women are currently in or past menopause; 1.2 billion will be by 2030. Women weren't required in US clinical trials until 1993, so most legacy evidence was built on male bodies. McKinsey estimates closing the women's-health gap is a US$1T+ GDP opportunity by 2040.

Virtual menopause clinics (US$99–$379/month, regional, prescription-bound) have validated the category. Nila owns the bigger half — moderated community, evidence-based research library, symptom and treatment guides, and a private companion at CAD $12.99/month, globally, for the populations clinics structurally don't serve (induced menopause, post-cancer, neurodivergent, trans and non-binary, women of colour, sole carers).

Sources: SVB Innovation in Women's Health 2025; Grand View Research FemTech market; NIH ORWH; McKinsey Health Institute / WEF, Closing the Women's Health Gap (2024).